Skip to main content

Site References

  1. Diagnosis and Treatment of Rosacea: State of the Art (v1.0)
  2. Baldwin 2012 (v1.0)
  3. NRS All about (v1.0)
  4. National Rosacea Society. https://www.rosacea.org/blog/2018/april/rosacea-awareness-month-marks-strides-in-spotting-life-disruptive-disorder. Accessed October 7, 2019.
  5. Blout et al 2002 (v1.0)
  6. Factors That May Trigger Rosacea Flare-Ups progetto rozex 2019 (v1.0)
  7. NRS 2010 incidence (v1.0)
  8. NRS 2020 All About Rosacea _ Rosacea.org (v1.0)
  9. https://www.rosacea.org/rosacea-review/2013/winter/acne-or-rosacea-accurate-diagnosis-is-key-to-treatment
  10. Rosacea: Beyond the visible online report. (v1.0)
  11. Antibiotic Resistance Threats in the United States, 2019 (v1.0)
  12. Centers for Disease Control and Prevention. https://www.cdc.gov/drugresistance/about.html. Accessed March 23, 2020.
  13. Baldwin_J Drugs Dermatol 2012 p 725 (v1.0)
  14. Oracea PI (v1.0)
  15. Galderma Laboratories, L.P.; data on file. Clinical Study Report SGT-54-01; January 8, 2020.
  16. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. doi:10.1016/j.jaad.2015.12.037
  17. Epsolay PI 4/2021 (v1.0)
  18. Soolantra PI_2015 (v1.0)
  19. Mirvaso PI 11/2017 (v1.0)
  20. ORACEA.com/hcp: Resource Hub - Clinical Studies. Del Rosso 2007. (v1.0)
  21. Galderma Laboratories, L.P.; data on file. Clinical Study Report SGT-54-02; March 26, 2020.
  22. Ci X, et al. Fundam Clin Pharmacol. 2009;23(4):449-55. (v1.0)
  23. Schaller M, et al. J Eur Acad Dermatol Venereol. 2017;31(11):1907-11.
  24. Schaller 2020. J Am Acad Dermatol. ANSWER (v1.0)